The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: An in vivo mouse model

Clinical Cancer Research

Volumn 7, Issue 6, 2001, Pages 1654-1660

  Fisher, J L ^a   Mackie, P S ^a   Howard, M L ^a   Zhou, H ^a   Choong, P F M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROCOLLAGEN; UROKINASE; UROKINASE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HISTOLOGY; IN SITU HYBRIDIZATION; METASTASIS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; TIBIA;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; IN SITU HYBRIDIZATION; LUNG; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; OSTEOSARCOMA; RECEPTORS, CELL SURFACE; RNA, MESSENGER; TIBIA; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034896298     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Osteosarcoma
2. Molecular aspects of tumor cell invasion and metastasis
3. Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer
4. Urokinase-type plasminogen activator: Proenzyme, receptor and inhibitors
5. Control of the IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
6. Type-1 plasminogen activator inhibitor in human breast carcinomas
7. Urokinase plasminogen activator levels and prognosis in 69 soft-tissue sarcomas
8. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice
9. Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma
10. Plasminogen-dependent activation of latent transforming growth factor β (TGF β) by growing cultures of osteoblast-like cells
11. Expression of parathyroid hormone-related protein in cells of osteoblast lineage
12. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone
13. Urokinase plasminogen activator system gene expression is increased in human breast carcinoma and its bone metastases - A comparison of normal breast tissue, non-invasive and invasive carcinoma and osseous metastases
14. Transforming growth factor β inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells
15. Morphological and biochemical characterization of four clonal osteogenic sarcoma lines of rat origin
16. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line
17. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1α
18. Plasminogen activators and their inhibitors in osteosarcomas and other bone tumours
19. Properties of transplantable osteogenic sarcoma and derived cell clones
20. Characterization of brain and bone-metastasizing clones elected from an ethylnitrosourea-induced rat mammary carcinoma
21. Metastatic model for human prostate cancer using orthotopic implantation in nude mice
22. Combined overexpression of urokinase, urokinase receptor and plasminogen activator inhibitor-1 is associated with breast cancer progression
23. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line
24. Antisense inhibition of urokinase: Effect on malignancy in a human osteosarcoma cell line
25. Binding and activation of plasminogen on the surface of osteosarcoma cells
26. Integrins and cancer
27. Elevated expression of secreted phosophoprotein I (osteopontin. 2ar) as a consequence of neoplastic transformation
28. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells
29. Osteopontin expression and distribution in human carcinomas
30. Vascular endothelial growth factor and osteopontin in tumor biology
31. Urokinase receptor and integrin partnership: Coordination of signaling for cell adhesion, migration and growth
32. Cell adhesion to matrix Gla protein and its inhibition by an Arg-Gly-Asp-containing peptide
33. Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein
34. Myofibroblastic stromal reaction in carcinoma of the breast: Variations of collagenous matrix and structural glycoproteins
35. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines